SCHEMBL614852

SCHEMBL614852

CCCCCCCCCCCCN(CC)CC

nearest known ligand 0.55

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
DNM1 Q05193 3/20 0.55
KCNH2 Q12809 12/20 0.52
PLA2G1B P04054 1/20 0.50
PLA2G2A P14555 1/20 0.50
TSHR P16473 1/20 0.50
THRB P10828 1/20 0.50
MGLL Q99685 1/20 0.43
CA12 O43570 1/20 0.42
CA1 P00915 1/20 0.42
CA2 P00918 1/20 0.42
CA9 Q16790 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL612402 1.00 DNM1 (0.55) DNM1KCNH2PLA2G1BPLA2G2ATSHR
SCHEMBL614713 1.00 DNM1 (0.55) DNM1KCNH2PLA2G1BPLA2G2ATSHR
SCHEMBL2336699 1.00 DNM1 (0.55) DNM1KCNH2PLA2G1BPLA2G2ATSHR
SCHEMBL613374 1.00 DNM1 (0.55) DNM1KCNH2PLA2G1BPLA2G2ATSHR
SCHEMBL3414531 1.00 DNM1 (0.55) DNM1KCNH2PLA2G1BPLA2G2ATSHR
SCHEMBL3414557 1.00 DNM1 (0.55) DNM1KCNH2PLA2G1BPLA2G2ATSHR
SCHEMBL487268 1.00 DNM1 (0.55) DNM1KCNH2PLA2G1BPLA2G2ATSHR
SCHEMBL613743 1.00 DNM1 (0.55) DNM1KCNH2PLA2G1BPLA2G2ATSHR
SCHEMBL14800063 1.00 DNM1 (0.55) DNM1KCNH2PLA2G1BPLA2G2ATSHR
SCHEMBL592260 1.00 DNM1 (0.55) DNM1KCNH2PLA2G1BPLA2G2ATSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 696 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4642829-B1 EPOXIDE-BASED COMPOSITION EVONIK OPERATIONS GMBH (DE) 2026-05-27 EP claimed
EP-4642829-A1 EPOXIDE-BASED COMPOSITION Evonik Operations GmbH (DE) 2025-11-05 EP claimed
US-20240343702-A1 ISOLATION METHOD FOR LACTIDE RACEMATE LG CHEM, LTD. (KR) 2024-10-17 US claimed
WO-2024141243-A1 EPOXIDE-BASED COMPOSITION EVONIK OPERATIONS GMBH (DE) 2024-07-04 WO claimed
CN-114231288-B Silicon etching liquid composition, pattern forming method, array substrate manufacturing method, and array substrate 东友精细化工有限公司 2023-12-26 CN claimed
EP-4273134-A1 ISOLATION METHOD FOR LACTIDE RACEMATE Lg Chem, Ltd. (KR) 2023-11-08 EP claimed
CN-116724029-A Process for the separation of racemic lactide 株式会社LG化学 2023-09-08 CN claimed
CN-113402705-B Polyether amine and preparation method and application thereof 中国石油化工股份有限公司 2023-05-05 CN claimed
WO-2022260430-A1 ISOLATION METHOD FOR LACTIDE RACEMATE 주식회사 엘지화학 2022-12-15 WO claimed
CN-114231288-A Silicon etching liquid composition, pattern forming method, array substrate manufacturing method, and array substrate 东友精细化工有限公司 2022-03-25 CN claimed
US-6613863-B2 Benzyltrialkylammonium carboxylate isocyanate trimerization catalysts DEGUSSA AG (DE) 2003-09-02 US claimed
US-20020120089-A1 Catalyst and process for preparing low-viscosity and color-reduced polyisocyanates containing isocyanurate groups DEGUSSA AG (DE) 2002-08-29 US claimed
EP-0653159-B1 Desinfecting composition SALKIN ANDRE (FR) 1999-08-18 EP claimed
EP-0361202-B1 Liquid detergent composition MITSUBISHI PETROCHEMICAL CO (JP) 1994-03-30 EP claimed
US-4548810-A AMINE SALTS FLEET BANK, NATIONAL ASSOCIATION 1985-10-22 US claimed
US-4450114-A Process for production of sulfuric acid semiesters SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1984-05-22 US claimed
US-4430513-A COBALT OR RHODIUM CARBONYL, CARBON-CARBON BOND FORMATION UOP INC. (US) 1984-02-07 US claimed
US-4410697-A CARBAMATE, AMINE, TERTIARY AMINE CATALYST REANAL FINOMVEGYSZERGYAR (HU) 1983-10-18 US claimed
US-4351765-A Process for the production of compounds having in the molecule at least one β-sulfatoethyl-sulfone group and at least one sulfonic acid group SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1982-09-28 US claimed
US-4057029-A Time-temperature indicator INFRATAB CORPORATION (US) 1977-11-08 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240343702-A1 ISOLATION METHOD FOR LACTIDE RACEMATE LCT, LDHB, LDHA DNM1 2292/4885KCNH2 3427/4885PLA2G1B 1386/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.